Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Percutaneous Needle Fasciotomy ± Corticosteroid Injection for Dupuytren Contracture (MCP Joint)
2022-501549-57-00Phase 3Authorised
- Sponsor
- Central Denmark Region
- Start
- Oct 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of methylprednisolone in Dupuytren's contracture (2 arms), sponsored by Central Denmark Region. Primary endpoint: Recurrence of metacarpophalangeal joint contracture. Planned start Oct 2022; status: authorised.
02
Drugs
methylprednisolone
03
Conditions
Dupuytren's contracture
Beyond the preview
Go deeper on 2022-501549-57-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-501549-57-00.